Financials

  • Market Capitalization 5.4299 M
  • Employee 9
  • Founded 2014
  • CEO N/A
  • Website www.dermatarx.com
  • Headquarter Delaware, United States
  • FIGI BBG011DJT0X2
  • Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-0
Price to sales ratio

Related tickers

#NamePrice24h %7d %1M %1Y %Market CapLast 7 Days
7484
ASBPW
Aspire Biopharma Holdings, Inc. - Warrant
0.0239 USD0.00%+19.50%+19.50%-56.23%7.88 M USD
7493
CDIOW
Cardio Diagnostics Holdings Inc. - Warrant
0.0152 USD0.00%+0.66%-16.02%+1.33%5.39 M USD
7495
MLECW
Moolec Science SA - Warrant
0.0169 USD-0.59%+32.03%+6.96%+14.19%5.43 M USD
7508
REVBW
Revelation Biosciences, Inc. - Warrant
0.0062 USD-37.37%-37.37%-10.14%-48.33%3.87 M USD

Frequently asked questions about Dermata Therapeutics, Inc. - Warrant

What is the Dermata Therapeutics, Inc. - Warrant stock price today?

The current price of Dermata Therapeutics, Inc. - Warrant (DRMAW) is 0.0123. Over the past 24 hours, the stock has changed by 0.00%. Follow the DRMAW chart for real-time price dynamics.

What is the stock ticker of Dermata Therapeutics, Inc. - Warrant?

Dermata Therapeutics, Inc. - Warrant trades under the ticker DRMAW. Tickers can differ by exchange, so always check the exchange and instrument details before trading.

Is Dermata Therapeutics, Inc. - Warrant stock going up?

DRMAW has changed by 0.00% over the last week, +23.00% over the last month, and -30.90% over the last year. Review the chart to see whether the current move is part of a broader trend.

What was Dermata Therapeutics, Inc. - Warrant net income for the last quarter?

Dermata Therapeutics, Inc. - Warrant reported net income of -1.85 M for the last quarter. The previous quarter showed -1.86 M, which means net income changed by +0.76%.

How many employees does Dermata Therapeutics, Inc. - Warrant have?

As of the latest available data, Dermata Therapeutics, Inc. - Warrant has 9 employees. Workforce size can provide additional context about the company's scale and operations.

How can I buy Dermata Therapeutics, Inc. - Warrant stock?

You can buy Dermata Therapeutics, Inc. - Warrant (DRMAW) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.

Should I invest in Dermata Therapeutics, Inc. - Warrant stock?

Investing in Dermata Therapeutics, Inc. - Warrant requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the DRMAW chart and related analysis on metatrader.com as part of your research.